Sava Revenue and Competitors

Location

N/A

Total Funding

Cannabis

Industry

Estimated Revenue & Valuation

  • Sava's estimated annual revenue is currently $22.1M per year.(i)
  • Sava's estimated revenue per employee is $270,000

Employee Data

  • Sava has 82 Employees.(i)
  • Sava grew their employee count by -8% last year.

Sava's People

NameTitleEmail/Phone
1
Co-founder and CMOReveal Email/Phone
2
Founder | CEOReveal Email/Phone
3
Customer Service Team ManagerReveal Email/Phone
4
Brand ManagerReveal Email/Phone
5
Operations ManagerReveal Email/Phone
6
Sr. Fulfillment Operations ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.1M33-40%N/AN/A
#2
$47.6M16420%$20MN/A
#3
$37.3M138-3%N/AN/A
#4
$10.1M490%$175.5MN/A
#5
$45.1M152-3%N/AN/A
#6
$23.8M889%N/AN/A
#7
$12.6M52-5%N/AN/A
#8
$86.5M2980%$12.3MN/A
#9
$2.4M15-12%N/AN/A
#10
$15.3M5142%$29MN/A
Add Company

What Is Sava?

SAVA is a curated marketplace for cannabis goods available for delivery throughout California.

keywords:N/A

N/A

Total Funding

82

Number of Employees

$22.1M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sava News

2022-04-17 - Cassava Sciences (NASDAQ:SAVA) has More Than Enough Funding to Function Until the Approval Process is Finished, but Investors may Need to be Ready for a Long Wait

Cassava Sciences, Inc.'s (NASDAQ:SAVA) a clinical stage biotechnology company, is developing a drug for Alzheimer - a neurodegenerative...

2022-04-17 - Hot Stocks: Homebuilders rally; CMPI, ACC jump on merger deals; SAVA falls to new low

Homebuilders rallied on signs of continued demand in the housing market. CMPI and ACC rose on separate deals to be acquired.

2022-04-17 - Wall Street darling Cassava Sciences is under fire as scientists question trial irregularities

Cassava Sciences was one of the fastest growing companies in the world last year after promising trials for its Alzheimer's drug.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.5M82-2%$120.7M
#2
$11.5M8255%$41.4M
#3
$11.5M8211%$80.4M
#4
$26.9M8232%$6.4M
#5
$10.7M82-1%$68.3M